1. Home
  2. ACIU vs EPSN Comparison

ACIU vs EPSN Comparison

Compare ACIU & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.14

Market Cap

221.9M

Sector

Health Care

ML Signal

HOLD

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$5.51

Market Cap

187.2M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIU
EPSN
Founded
2003
2005
Country
Switzerland
United States
Employees
122
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
221.9M
187.2M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
ACIU
EPSN
Price
$2.14
$5.51
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
256.1K
177.0K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
4.01%
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
N/A
N/A
Revenue This Year
$706.75
N/A
Revenue Next Year
$321.13
N/A
P/E Ratio
N/A
$276.00
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$4.20
52 Week High
$4.00
$6.65

Technical Indicators

Market Signals
Indicator
ACIU
EPSN
Relative Strength Index (RSI) 36.96 50.31
Support Level $2.15 $5.08
Resistance Level $2.66 $5.62
Average True Range (ATR) 0.15 0.21
MACD -0.02 0.04
Stochastic Oscillator 11.11 65.35

Price Performance

Historical Comparison
ACIU
EPSN

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

Share on Social Networks: